Median time to first skeletal-related event in the enzalutamide ( n = @ ) and placebo ( n = @ ) groups was @ months ( @ % CI @ to @ ) and @ months ( @ % CI @ to not yet reached ) , respectively ( hazard ratio -LSB- HR -RSB- @ -LSB- @ % CI @-@ -RSB- ; p = @ ) .